POC (point-of-care) bladder cancer test proves accurate:
This article was originally published in Clinica
Matritech's point-of-care (POC) test for bladder cancer is as accurate as the company's FDA-approved laboratory-based version of the test, according to a study of 96 individuals. The overall concordance between the POC NMP22 BladderChek test and Matritech's current NMP22 microplate format test was 95%, reports the Newton, Massachusetts firm. BladderChek works much like a home pregnancy test and can produce results while the patient is in the doctor's office. Current tests performed in a central laboratory take two to three days to deliver results, said the company.